Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Biden administration asks US supreme court to halt abortion pill restrictions

Limits slated to go into effect at 12.01am Saturday following lower court’s order revoking the FDA’s approval of mifepristone

The Guardian - US

DOJ, drugmaker ask SCOTUS to intervene in abortion drug case

WASHINGTON — The Justice Department and a pharmaceutical company on Friday asked the Supreme Court to intervene in the court fight over a commonly used abortion drug in order to keep a court ruling restricting availability of the drug from taking effect this weekend.

Tribune News Service

Abortion pill could be unavailable for months without Supreme Court action-U.S. DOJ

New court-imposed restrictions on the abortion pill mifepristone could cut off access to the drug entirely for months, the Biden administration and the drug's distributor, Danco Laboratories, said in petitions asking the U.S. Supreme Court to lift the curbs.

Reuters

From analysis to the latest developments in health,
read the most diverse news in one place.

The Unexpected Way The Texas Abortion Ruling Could Destroy Biotech

A judge's decision in Texas to outlaw an abortion drug undermines the foundation of all biotech stocks, a group of nearly 600 executives says.

Investors Business Daily

Commentary: Abortion pill ruling means more painful, later terminations

The conservative 5th Circuit has blocked part of a Texas judge’s decision to pull abortion drug mifepristone off the market, but leaves in place onerous and outdated restrictions that the Food and Drug Administration determined in 2016 were medically unnecessary.

Tribune News Service

Sarepta Tumbles As Report Of Internal FDA Strife Scorches Its Gene Therapy

Several FDA staffers were leaning toward rejecting a highly watched gene therapy from Sareptas, according to a report Thursday.

Investors Business Daily

Abortion’s new battleground: Mifepristone’s effect on women’s mental health

At the heart of the latest battle over abortion access is a federal judge’s ruling that cites concern about the mental health of women who choose to end their pregnancies.

Los Angeles Times

Read news from The Economist, FT, and more,
with one subscription

Trillions In Biotech Stock Gains Trace Back To This Financier

Frank did not grow up as son of a Wall Street banker. He began as the consummate outsider.

Investors Business Daily

Court preserves access to abortion drug, tightens rules

A federal appeals court has preserved access to an abortion drug for now but under tighter rules that would allow the drug only to be dispensed up to seven weeks, not 10, and not by mail

The Independent UK

Pharmaceutical executives challenge Texas court’s abortion pill ruling

Gilead Sciences and Pfizer join amicus brief

The Independent UK

US drug tsar warns xylazine tranquilizer mixed with fentanyl is ‘emerging threat’

Dr Rahul Gupta says drug has become increasingly common nationwide and is particularly dangerous when mixed with opioid fentanyl

The Guardian - US

US names veterinary drug, fentanyl mixture 'emerging threat'

The U.S. Office of National Drug Control Policy is designating the tranquilizer xylazine when mixed with fentanyl as an emerging threat

The Independent UK

Lisa Jarvis: Abortion pill ruling threatens pharmaceutical innovation

A Texas federal judge’s ruling to remove the 23-year-old drug mifepristone from the market not only threatens abortion access in the U.S. — it’s also an appalling sideswipe at the Food and Drug Administration’s authority and expertise.

Tribune News Service

Abortion drug rulings spur drugmaker worries about precedent

WASHINGTON — Experts worry two recent rulings challenging the Food and Drug Administration’s regulation of a drug used in medication abortions threaten to complicate the agency’s oversight and the pipeline for future research and drug approvals.

Tribune News Service

Get all your
news in one place.

100’s of premium titles.
One news app.

Salon

GOP sadism proudly on display

The abortion pill decision proves, yet again, that there's nothing "pro-life" about Republicans

Tribune News Service

Legal fight over abortion drug could quickly hit Supreme Court

WASHINGTON — The Justice Department and several Democrat-led states took steps Monday to preserve access to a commonly used medication abortion drug after dueling federal court rulings about its availability.

StockNews.com

2 Biotech Stocks That Are Screaming “SELL ME!”

The biotech sector is witnessing the headwinds from the banking crisis, layoffs, and the Inflation Reduction Act. So, fundamentally weak biotech stocks Ginkgo Bioworks Holdings (DNA) and Novavax (NVAX) might be best avoided. Read on.

Wales Online

Cancer and heart disease vaccines could be ready 'by the end of the decade'

The speed of which the Covid jab was developed has "unspooled" medical advancements

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - US

Abortion pill case: where does the lawsuit against the pill currently stand?

The fifth circuit court of appeals is considering the future of mifepristone after the supreme court blocked new restrictions

Salon

FDA approval of abortion pill suspended

Biden has one week to appeal

The Texas Tribune

Federal judge in Texas suspends FDA approval of abortion pill

The ruling from U.S. District Judge Matthew Kacsmaryk in Amarillo could potentially upend access to medication abortion nationwide.

ABC News

Details of Geraldton drug bust, then Australia's biggest meth seizure, can finally be revealed

After more than five years, three trials and countless hours of legal argument, details can finally be revealed of the brazen attempt to import 1.2 tonnes of meth into Western Australia.

StockNews.com

3 'A-Rated' Pharmaceutical Stocks UNDER $15 to Own in April

The pharmaceutical industry is positioned for considerable growth in the upcoming years, thanks to increased demand, investments in research and development, and the expansion of e-pharmacy channels. Therefore, A-rated pharmaceutical stocks Astellas Pharma (ALPMY), Ono Pharmaceutical (OPHLY), and Santen Pharmaceutical (SNPHY), trading under $15, could be worth owning in April.…

WEKU

FDA pulls the only approved drug for preventing premature birth off the market

The drug had been fast-tracked for approval under the agency's accelerated approval program, and has been available for more than a decade, despite the drugmaker's failure to prove that it works.

The Independent UK

FDA forces unproven premature birth drug Makena off market

The Food and Drug Administration is ordering an unproven drug intended to prevent premature births off the market

1 … 52 53 54 55

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Food and Drug Administration

345 stories

APA

240 stories

the Food and Drug Administration

196 stories

Australian Federal Police

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.